Testing effectiveness (Phase 2)Study completedNCT02034110
What this trial is testing
Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers
Who this might be right for
Cancer
Novartis Pharmaceuticals 206